These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38065340)

  • 21. Association of Microsatellite Instability and Gene Expression Profile in Colorectal Carcinoma and Potential Implications for Therapy.
    Kibriya MG; Jasmine F; Khamkevych Y; Raza M; Kamal M; Bissonnette M; Ahsan H
    Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541076
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeting MSS colorectal cancer with immunotherapy: are we turning the corner?
    Wang C; Fakih M
    Expert Opin Biol Ther; 2021 Oct; 21(10):1347-1357. PubMed ID: 34030532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chr20q Amplification Defines a Distinct Molecular Subtype of Microsatellite Stable Colorectal Cancer.
    Zhang B; Yao K; Zhou E; Zhang L; Cheng C
    Cancer Res; 2021 Apr; 81(8):1977-1987. PubMed ID: 33619118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review.
    Guven DC; Kavgaci G; Erul E; Syed MP; Magge T; Saeed A; Yalcin S; Sahin IH
    Oncologist; 2024 May; 29(5):e580-e600. PubMed ID: 38309719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
    Lin A; Zhang J; Luo P
    Front Immunol; 2020; 11():2039. PubMed ID: 32903444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer.
    Quan Y; He J; Zou Q; Zhang L; Sun Q; Huang H; Li W; Xie K; Wei F
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37597850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SET facilitates immune escape of microsatellite stability colorectal cancer by inhibiting c-Myc degradation.
    Gao L; Li Y; Wang H; Liu J; Zhang R; Shan W; Zeng L; Zhao Q; Li Y; Liu J
    Cancer Sci; 2024 Oct; ():. PubMed ID: 39420583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of immune checkpoint inhibitors for patients with advanced stage microsatellite stable colorectal cancer and high tumor mutation burden: quantity or quality?
    Vegivinti CTR; Gonzales Gomez C; Syed M; Ferrell M; Cheng S; Singhi A; Saeed A; Sahin IH
    Expert Opin Biol Ther; 2023; 23(7):595-601. PubMed ID: 37318031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and Radiological Features of Microsatellite Stable Colorectal Cancer Cases With Dramatic Responses to Immunotherapy.
    Keenan BP; VAN Loon K; Khilnani AD; Fidelman N; Behr SC; Atreya CE; Oh DY
    Anticancer Res; 2021 Jun; 41(6):2985-2992. PubMed ID: 34083289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients.
    Wang D; Zhang H; Xiang T; Wang G
    Front Immunol; 2021; 12():762341. PubMed ID: 34721435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Durable complete response to pembrolizumab in microsatellite stable colorectal cancer.
    Gomar M; Najafi M; Aghili M; Cozzi S; Jahanbakhshi A
    Daru; 2021 Dec; 29(2):501-506. PubMed ID: 34254265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shaping immune landscape of colorectal cancer by cholesterol metabolites.
    Bai Y; Li T; Wang Q; You W; Yang H; Xu X; Li Z; Zhang Y; Yan C; Yang L; Qiu J; Liu Y; Chen S; Wang D; Huang B; Liu K; Song BL; Wang Z; Li K; Liu X; Wang G; Yang W; Chen J; Hao P; Zhang Z; Wang Z; Zhu ZJ; Xu C
    EMBO Mol Med; 2024 Feb; 16(2):334-360. PubMed ID: 38177537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting euchromatic histone lysine methyltransferases sensitizes colorectal cancer to histone deacetylase inhibitors.
    Bamberg LV; Heigwer F; Wandmacher AM; Singh A; Betge J; Rindtorff N; Werner J; Josten J; Skabkina OV; Hinsenkamp I; Erdmann G; Röcken C; Ebert MP; Burgermeister E; Zhan T; Boutros M
    Int J Cancer; 2022 Nov; 151(9):1586-1601. PubMed ID: 35666536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARγ induces PD-L1 expression in MSS+ colorectal cancer cells.
    Gutting T; Hauber V; Pahl J; Klapproth K; Wu W; Dobrota I; Herweck F; Reichling J; Helm L; Schroeder T; Li B; Weidner P; Zhan T; Eckardt M; Betge J; Belle S; Sticht C; Gaiser T; Boutros M; Ebert MPA; Cerwenka A; Burgermeister E
    Oncoimmunology; 2021 May; 10(1):1906500. PubMed ID: 34026331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters.
    Pakish JB; Zhang Q; Chen Z; Liang H; Chisholm GB; Yuan Y; Mok SC; Broaddus RR; Lu KH; Yates MS
    Clin Cancer Res; 2017 Aug; 23(15):4473-4481. PubMed ID: 28264871
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment.
    Bai J; Chen H; Bai X
    J Clin Lab Anal; 2021 Jun; 35(6):e23810. PubMed ID: 33938589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment.
    Zheng Z; Wieder T; Mauerer B; Schäfer L; Kesselring R; Braumüller H
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.
    Johansen AFB; Kassentoft CG; Knudsen M; Laursen MB; Madsen AH; Iversen LH; Sunesen KG; Rasmussen MH; Andersen CL
    BMC Cancer; 2019 Oct; 19(1):971. PubMed ID: 31638937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential Mechanism of Immune Evasion Associated with the Master Regulator ASCL2 in Microsatellite Stability in Colorectal Cancer.
    Yang Q; Huang G; Li L; Li E; Xu L
    J Immunol Res; 2021; 2021():5964752. PubMed ID: 33628843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.